There is intense competition in the global market for anti-allergic drugs, specifically those used in the treatment of allergic rhinitis. Therefore, pharmaceutical companies need to regularly monitor the performance of their products against the inline and pipeline products of competitors.
Against this industry backdrop, WNS conducted a market assessment study for anti-allergic drugs with a special focus on markets such as the U.S., European Union (EU), Japan, and Rest of the World (RoW). This detailed research-led study comprised:
WNS also leveraged analytics to identify the unmet needs of the market for treatment of allergic rhinitis
WNS' market assessment study can enable pharmaceutical clients to methodically arrive at competitive differentiation, thereby strengthening business strategy and driving growth. Pharmaceutical companies can leverage these actionable insights to make more informed decisions for future investments in drug research.
*The ATC / DDD system classifies therapeutic drugs. The purpose of the ATC / DDD system is to serve as a tool for drug utilization research in order to improve quality of drug use. The ATC system is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).
Disclaimer: WNS performs customized studies for its clients, and does not offer subscription-based reporting services.
Join the conversation
26 September 2021
16 October 2019
16 November 2022